Search

Your search keyword '"Siegel, Jeffrey"' showing total 689 results

Search Constraints

Start Over You searched for: Author "Siegel, Jeffrey" Remove constraint Author: "Siegel, Jeffrey"
689 results on '"Siegel, Jeffrey"'

Search Results

303. Volatile organic compound and particulate matter emissions from an ultrasonic essential oil diffuser.

304. Efficacy and Safety of Tocilizumab for the Treatment of Systemic Sclerosis: Results from a Phase 3 Randomized Controlled Trial

311. Use of a high-flow extractor to reduce aerosol exposure in tracheal intubation.

312. Bacterial colonization and succession in a newly opened hospital

313. Systematically omitting indoor air quality: sub-standard guidance for shelters, group homes and long-term care in Ontario during the COVID-19 pandemic.

315. Feast or Famine.

316. Avoiding Legal Land Mines When Interviewing Candidates.

317. Book reviews.

318. Book reviews.

319. Book reviews.

320. Study of superconducting systems using scanning Hall probe microscopy.

321. How balance will fuel company of the future.

322. Laboratory Measurements to Quantify the Effect of Bypass on Filtration Efficiency.

323. Radon emanation fractions from concretes containing fly ash and metakaolin.

324. Evaluation of three common green building materials for ozone removal, and primary and secondary emissions of aldehydes.

325. Performance of nanofibrous media in portable air cleaners.

326. YOU CAN'T MAKE THESE THINGS UP.

327. Energy use in residential buildings: Analyses of high-efficiency filters and HVAC fans.

328. Personal-Level Protective Actions Against Particulate Matter Air Pollution Exposure: A Scientific Statement From the American Heart Association.

330. Phthalates and organophosphates in settled dust and HVAC filter dust of U.S. low-income homes: Association with season, building characteristics, and childhood asthma.

333. Phthalates and polybrominated diphenyl ethers in retail stores.

334. Contributors

336. Analysis of life cycle cost methods for heating, ventilation, and air conditioning systems in hospitals

337. Tuberculosis Associated with Infliximab, a Tumor Necrosis Factor α–Neutralizing Agent.

338. Science tells us that portable air filters reduce infection risk. It's time for public health authorities to make this clear.

339. Indoor bioaerosols and asthma: Overview, implications, and mitigation strategies.

340. Surrogate Markers and Clinical Outcomes.

341. Considerations from an International Regulatory and Pharmaceutical Industry (IQ MPS Affiliate) Workshop on the Standardization of Complex In Vitro Models in Drug Development.

342. Widespread occurrence of pesticides in low-income housing.

343. Estimating Indoor Pollutant Loss Using Mass Balances and Unsupervised Clustering to Recognize Decays.

344. FDA/Arthritis Foundation osteoarthritis drug development workshop recap: Assessment of long-term benefit.

346. Modeling Clothing as a Vector for Transporting Airborne Particles and Pathogens across Indoor Microenvironments.

347. Long-Term Safety and Efficacy of Tocilizumab in Early Systemic Sclerosis-Interstitial Lung Disease: Open-Label Extension of a Phase 3 Randomized Controlled Trial.

348. Establishing a Public Resource for Acceptable Surrogate Endpoints to Support FDA Marketing Applications.

349. Indoor exposure to phthalates and polycyclic aromatic hydrocarbons (PAHs) to Canadian children: the Kingston allergy birth cohort.

350. Modeling the Removal of Water-Soluble Trace Gases from Indoor Air via Air Conditioner Condensate.

Catalog

Books, media, physical & digital resources